{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T05:26:44Z","timestamp":1792301204090,"version":"4.4.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Institute of Pharmacology Polish Academy of Sciences Krakow"},{"name":"Project of Interdisciplinary PhD Studies \u201cMolecular Sciences for Medicine\u201d"},{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.pharep.2017.01.032","type":"journal-article","created":{"date-parts":[[2017,2,8]],"date-time":"2017-02-08T09:01:20Z","timestamp":1486544480000},"page":"566-574","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Antidepressant-like effect of 1,2,3,4-tetrahydroisoquinoline and its methyl derivative in animal models of depression"],"prefix":"10.1007","volume":"69","author":[{"given":"Edyta","family":"Mo\u017cd\u017ce\u0144","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"W\u0105sik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irena","family":"Roma\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerzy","family":"Michaluk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucyna","family":"Antkiewicz-Michaluk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"10.1016\/j.pharep.2017.01.032_bib0005","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1136\/jnnp.52.6.724","article-title":"Major depression in Parkinson\u2019s disease and the mood response to intravenous methylphenidate: possible role of the hedonic dopamine synapse","volume":"52","author":"Cantello","year":"1989","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.pharep.2017.01.032_bib0010","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/cne.902870308","article-title":"Alterations in catecholamine neurons of the locus coeruleus in senile dementia of Alzheimer type and in Parkinson\u2019s disease with and without dementia and depression","volume":"287","author":"Chan-Palay","year":"1989","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.pharep.2017.01.032_bib0015","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/0028-3908(87)90110-9","article-title":"Pharmacological characteristics of tremor, rigidity and hypokinesia induced by reserpine in rats","volume":"26","author":"Colpaert","year":"1987","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharep.2017.01.032_bib0020","first-page":"667","article-title":"Action of antidepressant neuroleptics chlorprothixene and levomepromazine of the central noradrenergic system comparison with other antidepressants","volume":"37","author":"Antkiewicz-Michaluk","year":"1985","journal-title":"Pol J Pharmacol Pharm"},{"key":"10.1016\/j.pharep.2017.01.032_bib0025","first-page":"1","article-title":"Hypotheses concerning the mechanism of action of antidepressant drugs","volume":"100","author":"Maj","year":"1984","journal-title":"Rev Physiol Biochem Pharmacol"},{"key":"10.1016\/j.pharep.2017.01.032_bib0030","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF00449803","article-title":"New perspectives on the molecular pharmacology of affective disorders","volume":"238","author":"Sulser","year":"1989","journal-title":"Eur Arch Psych Neurol"},{"key":"10.1016\/j.pharep.2017.01.032_bib0035","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S0025-6196(12)61375-5","article-title":"Pharmacology of antidepressants \u2212characteristics of the ideal drug","volume":"69","author":"Richelson","year":"1994","journal-title":"Mayo Clinic Proc"},{"key":"10.1016\/j.pharep.2017.01.032_bib0040","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0014-2999(00)00565-3","article-title":"Antidepressants: past, present and future","volume":"405","author":"Vetulani","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharep.2017.01.032_bib0045","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1472-8206.1990.tb01016.x","article-title":"Is it possible to predict the activity of a new antidepressant in animals with simple psychopharmacological test","volume":"4","author":"Bourin","year":"1990","journal-title":"Fund Clin Pharmacol"},{"key":"10.1016\/j.pharep.2017.01.032_bib0050","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/BF02244133","article-title":"Effect of repetitive electroconvulsive treatment on sensitivity to pain and on [3H]-nitrendipine binding sites in cortical and hippocampal membranes","volume":"101","author":"Antkiewicz-Michaluk","year":"1990","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharep.2017.01.032_bib0055","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/BF02244321","article-title":"Role of calcium channels in effects of antidepressant drugs on responsiveness to pain","volume":"105","author":"Antkiewicz-Michaluk","year":"1991","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharep.2017.01.032_bib0060","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/BF00508340","article-title":"Chronic treatment with imipramine: further functional evidence for the enhanced noradrenaline transmission in flexor reflex activity","volume":"322","author":"Maj","year":"1983","journal-title":"Naunyn-Schmied Arch Pharmacol"},{"key":"10.1016\/j.pharep.2017.01.032_bib0065","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1080\/078538902320772106","article-title":"The role of CREB and other transcription factors in the pharmacotherapy and etiology of depression","volume":"34","author":"Sulser","year":"2002","journal-title":"Ann Med"},{"key":"10.1016\/j.pharep.2017.01.032_bib0070","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/978-3-0348-9315-2_10","article-title":"Tetrahydroisoquinolines and beta-carbolines: putative natural substances in plants and mammals","volume":"29","author":"Rommelspacher","year":"1985","journal-title":"Prog Drug Res"},{"key":"10.1016\/j.pharep.2017.01.032_bib0075","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0024-3205(88)90115-4","article-title":"Presence of tetrahydroisoquinoline and 1-methyl-tetrahydroisoquinoline in foods: compounds related to Parkinson\u2019s disease","volume":"43","author":"Makino","year":"1988","journal-title":"Life Sci"},{"key":"10.1016\/j.pharep.2017.01.032_bib0080","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0378-4347(00)82740-1","article-title":"Presence of tetrahydroisoquinoline, a parkinsonism-related compound, in foods","volume":"493","author":"Niwa","year":"1989","journal-title":"J Chromatogr"},{"key":"10.1016\/j.pharep.2017.01.032_bib0085","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0006-2952(98)00142-7","article-title":"Isoquinoline derivatives as endogenous neurotoxins in the etiology of Parkinson's disease","volume":"56","author":"McNaught","year":"1998","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharep.2017.01.032_bib0090","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0304-3940(99)00786-7","article-title":"Regional distribution of parkinsonism-preventing endogenous tetrahydroisoquinoline derivatives and an endogenous parkinsonism-preventing substance-synthesizing enzyme in monkey brain","volume":"276","author":"Yamakawa","year":"1999","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharep.2017.01.032_bib0095","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0168-0102(97)00083-7","article-title":"Isoquinoline neurotoxins in the brain and Parkinson's disease","volume":"29","author":"Nagatsu","year":"1997","journal-title":"Neurosci Res"},{"key":"10.1016\/j.pharep.2017.01.032_bib0100","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1471-4159.1989.tb09170.x","article-title":"Oxidation of N-methyl-1,2,3,4-tetrahydroisoquinoline into the N-methyl-isoquinolinium ion by monoamine oxidase","volume":"52","author":"Naoi","year":"1989","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharep.2017.01.032_bib0105","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0304-3940(98)00913-6","article-title":"Biosynthesis of a parkinsonism-preventing substance, 1-methyl-1,2,3,4-tetrahydroisoquinoline, is inhibited by parkinsonism-inducing compounds in rat brain mitochondrial fraction","volume":"259","author":"Yamakawa","year":"1999","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharep.2017.01.032_bib0110","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1006\/bbrc.1997.6946","article-title":"Isolation of 1-methyl-1,2,3,4-tetrahydroisoquinoline-synthesining enzyme from rat brain: a possible Parkinson\u2019s disease-preventing enzyme","volume":"236","author":"Yamakawa","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharep.2017.01.032_bib0115","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0161-813X(03)00099-8","article-title":"Dopamine-derived salsolinol derivatives as endogenous monoamine oxidase inhibitors: occurrence, metabolism and function in human brains","volume":"25","author":"Naoi","year":"2004","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.pharep.2017.01.032_bib0120","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.brainres.2003.10.023","article-title":"Disposition of 1,2,3,4-tetrahydroisoquinoline in the brain of male Wistar and Dark Agouti rats","volume":"996","author":"Lorenc-Koci","year":"2004","journal-title":"Brain Res"},{"key":"10.1016\/j.pharep.2017.01.032_bib0125","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.brainres.2004.02.044","article-title":"Effect of 1,2,3,4-tetrahydroisoquinoline administration under conditions of CYP2D inhibition on dopamine metabolism, level of tyrosine hydroxylase proteinand the binding of [3H]GBR12,935 to dopamine transporter in the rat nigrostriatal, dopaminergic system","volume":"1009","author":"Lorenc-Koci","year":"2004","journal-title":"Brain Res"},{"key":"10.1016\/j.pharep.2017.01.032_bib0130","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0014-2999(03)01565-6","article-title":"1-Methyl-1,2,3,4-tetrahydroisoquinoline protects against rotenone-induced mortality and biochemical changes in rat brain","volume":"466","author":"Antkiewicz-Michaluk","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharep.2017.01.032_bib0135","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1017\/S1461145703004036","article-title":"Protective effect of 1-methyl-1,2,3,4-tetrahydroisoquinoline against dopaminergic neurodegeneration in the extrapyramidal structures produced by intracerebral injection of rotenone","volume":"7","author":"Antkiewicz-Michaluk","year":"2004","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pharep.2017.01.032_bib0140","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.brainres.2005.04.039","article-title":"Treatment with 1,2,3,4-tetrahydroisoquinoline affects the levels of nitric oxide, S-nitrosothiols, glutathione and the enzymatic activity of gamma-glutamyl transpeptidase in the dopaminergic structures of rat brain","volume":"1049","author":"Lorenc-Koci","year":"2005","journal-title":"Brain Res"},{"key":"10.1016\/j.pharep.2017.01.032_bib0145","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/j.1471-4159.2006.03756.x","article-title":"The mechanism of 1,2,3,4-tetrahydroisoquinolines neuroprotection: the importance of free radicals scavenging properties and inhibition of glutamate-induced excitotoxicity","volume":"97","author":"Antkiewicz-Michaluk","year":"2006","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharep.2017.01.032_bib0150","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1046\/j.1471-4159.2001.00391.x","article-title":"Different action on dopamine catabolic pathways of two endogenous 1,2,3,4-tetrahydroisoquinolines with similar antidopaminergic properties","volume":"78","author":"Antkiewicz-Michaluk","year":"2001","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharep.2017.01.032_bib0155","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00702-006-0546-y","article-title":"An endogenous neuroprotectant substance, 1-methyl-1,2,3,4-tetrahydroisoquinoline (1MeTIQ), prevents the behavioral and neurochemical effects of cocaine reinstatement in drug-dependent rats","volume":"114","author":"Antkiewicz-Michaluk","year":"2007","journal-title":"J Neural Transm"},{"key":"10.1016\/j.pharep.2017.01.032_bib0160","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF01245003","article-title":"Naturally-occuring isoquinolines perturb monoamine metabolism in the brain: studied by in vivo microdialysis","volume":"94","author":"Maruyama","year":"1993","journal-title":"J Neural Transm Gen Sect"},{"key":"10.1016\/j.pharep.2017.01.032_bib0165","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0306-4522(99)00511-4","article-title":"Effect of acute and chronic administration of 1,2,3,4-tetrahydroisoquinoline on muscle tone, metabolism of dopamine in the striatum and tyrosine hydroxylase immunocytochemistry in the substantia nigra, in rats","volume":"95","author":"Lorenc-Koci","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharep.2017.01.032_bib0170","first-page":"727","article-title":"Inhibition of rodent brain monoamine oxidase and tyrosine hydroxylase by endogenous compounds \u22121,2,3,4-tetrahydroisoquinoline alkaloids","volume":"56","author":"Patsenka","year":"2004","journal-title":"Pol J Pharmacol"},{"key":"10.1016\/j.pharep.2017.01.032_bib0175","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ejphar.2014.01.075","article-title":"1,2,3,4-Tetrahydroisoquinoline produces an antidepressant-like effect in the forced swim test and chronic mild stress model of depression in the rat: neurochemical correlates","volume":"729","author":"Mo\u017cd\u017ce\u0144","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharep.2017.01.032_bib0180","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0014-2999(78)90118-8","article-title":"Behavioural despair in rats: a new model sensitive to antidepressant treatments","volume":"47","author":"Porsolt","year":"1978","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharep.2017.01.032_bib0185","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1254\/jphs.FP0072150","article-title":"Selegilin exerts antidepressant-like effects during the forced swim test in adrenocorticotropic hormone-treated rats","volume":"106","author":"Kitamura","year":"2008","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.pharep.2017.01.032_bib0190","first-page":"327","article-title":"Behavioral despair in mice: a primary screening test for antidepressants","volume":"229","author":"Porsolt","year":"1977","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"10.1016\/j.pharep.2017.01.032_bib0195","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.neulet.2005.02.026","article-title":"Evidence for the involvement of the opioid system in the agmatine antidepressant-like effect in the forced swimming test","volume":"381","author":"Zomkowski","year":"2005","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharep.2017.01.032_bib0200","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.pbb.2009.11.003","article-title":"Antidepressant effect of the extracts from Fructus Akebiae","volume":"94","author":"Zhou","year":"2010","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharep.2017.01.032_bib0205","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","article-title":"The tail suspension test: a new method for screening antidepressants in mice","volume":"85","author":"Steru","year":"1985","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pharep.2017.01.032_bib0210","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/ptr.1697","article-title":"Behavioural and biochemical effects of fractions prepared fromBanxia Houpudecoction in depression models in mice","volume":"19","author":"Wang","year":"2005","journal-title":"Phytother Res"},{"key":"10.1016\/j.pharep.2017.01.032_bib0215","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0024-3205(79)90275-3","article-title":"Inhibition of biogenic amines uptake by imipramine, desipramine, 2 OH-imipramine and 2 OH-desipramine in rat brain","volume":"24","author":"Javaid","year":"1979","journal-title":"Life Sci"},{"key":"10.1016\/j.pharep.2017.01.032_bib0220","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/00004850-199112003-00002","article-title":"Depression and 5-HT","volume":"6","author":"Deakin","year":"1991","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.pharep.2017.01.032_bib0225","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0149-7634(94)00050-B","article-title":"Role of the serotonergic system in the forced swimming test","volume":"19","author":"Borsini","year":"1995","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pharep.2017.01.032_bib0230","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/BF02245592","article-title":"Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants","volume":"121","author":"Detke","year":"1995","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pharep.2017.01.032_bib0235","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1172\/JCI118492","article-title":"Specific genetic deficiencies of the A and B isoenzymes of monoamine oxidase are characterized by distinct neurochemical and clinical phenotypes","volume":"97","author":"Lenders","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharep.2017.01.032_bib0240","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0014-2999(97)00115-5","article-title":"Partial role of 5-HT3, and 5-HT2, receptors in the activity of antidepressants in the mouse forced swimming test","volume":"325","author":"Redrobe","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharep.2017.01.032_bib0245","first-page":"285","article-title":"On the role of noradrenergic neurotransmission in the action of desipramine and amitryptyline in animal models of depression","volume":"38","author":"Danysz","year":"1986","journal-title":"Pol J Pharmacol Pharm"},{"key":"10.1016\/j.pharep.2017.01.032_bib0250","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/0028-3908(83)90024-2","article-title":"Involvement of \u03b1 \u2212and \u03b21-adrenergic mechanisms in the immobility-reducing action of desipramine in the forced swimming test","volume":"22","author":"Kitada","year":"1983","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharep.2017.01.032_bib0255","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/00008877-200403000-00008","article-title":"The effect of combined treatment with imipramine and amantadine on the behavioral reactivity of central \u03b11-adrenergic system in rats","volume":"15","author":"Dziedzicka-Wasylewska","year":"2004","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pharep.2017.01.032_bib0260","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/BF02431541","article-title":"Additive effects of clonidine and antidepressant drugs in the mouse forced-swimming test","volume":"96","author":"Malinge","year":"1988","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharep.2017.01.032_bib0265","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1177\/026988110101500104","article-title":"Selective imidazoline I2 ligands do not show antidepressant-like activity in the forced swim test in mice","volume":"15","author":"O\u2018Neill","year":"2001","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pharep.2017.01.032_bib0270","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0006-2952(79)90108-4","article-title":"Inhibition of neuronal uptake of 3H-biogenic amines into rat cerebral cortex by partially and fully saturated derivatives of imipramine and desipramine. The importance of the aromatic ring in adrenergic amines \u2212part 3","volume":"28","author":"Grunewald","year":"1979","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharep.2017.01.032_bib0275","series-title":"13th International Symposium on Molecular and Physiological Aspects of Regulatory Processes of the Organism","first-page":"344","article-title":"Tetrahydroisoquinoline alkaloids as endogenous inhibitors of brain monoamine oxidase, tyrosine hydroxylase and uptake of monoamines: in vitro study","author":"Patsenka","year":"2004"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114016302134?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114016302134?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:36:56Z","timestamp":1752611816000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2017.01.032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S1734114016302134"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2017.01.032","relation":{},"ISSN":["1734-1140"],"issn-type":[{"value":"1734-1140","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antidepressant-like effect of 1,2,3,4-tetrahydroisoquinoline and its methyl derivative in animal models of depression","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharep.2017.01.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Sp. z o.o. on behalf of Institute of Pharmacology, Polish Academy of Sciences.","name":"copyright","label":"Copyright"}]}}